NVIDIA CUDA-Q Boosts Norma's Quantum AI Algorithm Performance by 73x for Drug Development
PorAinvest
lunes, 1 de septiembre de 2025, 9:04 am ET1 min de lectura
NVDA--
The project leveraged NVIDIA CUDA-Q, which simplifies the integration of GPUs and QPUs, supporting quantum-classical hybrid operations. By running quantum AI algorithms such as QLSTM, QGAN, and QCBM on CUDA-Q, Norma observed substantial performance improvements. Specifically, the execution of an 18-qubit quantum circuit was approximately 60.14 to 73.32 times faster, while the loss function-based correction process was about 33.69 to 41.56 times faster compared to traditional CPU-based methods [1].
Norma's CEO, Hyunchul Jung, highlighted the practical potential of quantum technologies, stating, "This project is a meaningful example of collaboration between domestic and international quantum technology companies and hospitals, showcasing the practical potential of quantum technologies." The company plans to expand its performance testing of quantum AI algorithms across various sectors, including healthcare, biotechnology, defense, and finance [1].
This breakthrough demonstrates the viability of quantum AI in drug discovery and other fields, potentially reducing development costs and time. As quantum computing technology continues to evolve, such collaborations and advancements could significantly impact the financial landscape by enabling faster and more efficient solutions in various industries.
References:
[1] https://www.prnewswire.com/news-releases/norma-completes-quantum-ai-algorithm-validation-on-nvidia-302541601.html
Norma, a quantum computing company, has validated the performance of its quantum AI algorithms on NVIDIA CUDA-Q, achieving speeds up to 73 times faster in drug development. The company has secured use cases for quantum AI in drug development and plans to expand validation efforts into various fields. Norma is independently developing quantum AI algorithms applicable across sectors such as biotechnology, defense, and finance.
Norma, a leading quantum computing company, has successfully validated the performance of its quantum AI algorithms on NVIDIA CUDA-Q, achieving computational speeds up to 73 times faster in drug development. This significant advancement was demonstrated in a collaborative project with Kyung Hee University Hospital at Gangdong, aiming to discover novel drug candidates [1].The project leveraged NVIDIA CUDA-Q, which simplifies the integration of GPUs and QPUs, supporting quantum-classical hybrid operations. By running quantum AI algorithms such as QLSTM, QGAN, and QCBM on CUDA-Q, Norma observed substantial performance improvements. Specifically, the execution of an 18-qubit quantum circuit was approximately 60.14 to 73.32 times faster, while the loss function-based correction process was about 33.69 to 41.56 times faster compared to traditional CPU-based methods [1].
Norma's CEO, Hyunchul Jung, highlighted the practical potential of quantum technologies, stating, "This project is a meaningful example of collaboration between domestic and international quantum technology companies and hospitals, showcasing the practical potential of quantum technologies." The company plans to expand its performance testing of quantum AI algorithms across various sectors, including healthcare, biotechnology, defense, and finance [1].
This breakthrough demonstrates the viability of quantum AI in drug discovery and other fields, potentially reducing development costs and time. As quantum computing technology continues to evolve, such collaborations and advancements could significantly impact the financial landscape by enabling faster and more efficient solutions in various industries.
References:
[1] https://www.prnewswire.com/news-releases/norma-completes-quantum-ai-algorithm-validation-on-nvidia-302541601.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios